Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
British Journal of Haematology
|
April 27, 2012
Organ-specific management and supportive care in chronic graft-versus-host disease
Fiona L Dignan, Julia J Scarisbrick, Jacqueline Cornish, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
Sudhir Tauro, Charles Craddock, Karl Peggs, et al.
Blood
|
August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosis
David C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Haematologica
|
June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
Niels Weinhold, Hans J Salwender, David A Cairns, et al.
International Journal of Clinical Practice
|
October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)
Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Leukemia
|
March 12, 2020
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
Vallari Shah, Amy L Sherborne, David C Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
Martin F Kaiser, Andrew Hall, Katrina Walker, et al.
Blood
|
September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
David C Johnson, Sophie Corthals, Christine Ramos, et al.
The Journal of Urology
|
January 15, 2013
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk
Ajay Nehra, Graham Jackson, Martin Miner, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
British Journal of Haematology
|
April 27, 2012
Organ-specific management and supportive care in chronic graft-versus-host disease
Fiona L Dignan, Julia J Scarisbrick, Jacqueline Cornish, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
Sudhir Tauro, Charles Craddock, Karl Peggs, et al.
Blood
|
August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosis
David C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Haematologica
|
June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
Niels Weinhold, Hans J Salwender, David A Cairns, et al.
International Journal of Clinical Practice
|
October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)
Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Leukemia
|
March 12, 2020
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
Vallari Shah, Amy L Sherborne, David C Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
Martin F Kaiser, Andrew Hall, Katrina Walker, et al.
Blood
|
September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
David C Johnson, Sophie Corthals, Christine Ramos, et al.
The Journal of Urology
|
January 15, 2013
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk
Ajay Nehra, Graham Jackson, Martin Miner, et al.
Page
of 26